Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Transtec shown to be safe and effective for treatment of cancer pain

Feb. 8, 2007

Avicena completes dose-escalating portion of chronic toxicology study of PD- 02

Feb. 8, 2007

elbion and Wyeth team up on PDE10 inhibitors for CNS disorders

Feb. 8, 2007

Treatment completed in phase III trials of Miraxion in Huntington's disease

Feb. 7, 2007

Novel activation mechanism for the pain-sensing TRPA1 channel / News in Context

Feb. 7, 2007

NF-kappaB inhibitors inhibit Abeta production in vitro: potential efficacy in AD

Feb. 7, 2007

Blockade of the orexin OX1/OX2 receptors with ACT-078573 promotes sleep in rats, dogs and humans

Feb. 6, 2007

Shionogi and Lilly to codevelop and comarket duloxetine in Japan

Feb. 6, 2007

Neurochem completes North American phase III study of tramiprosate

Feb. 6, 2007

Methylphenidate to commence clinical trial for the treatment of cancer-related fatigue

Feb. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...